Related Experiment Videos
Hepatic mensenchymal hamartoma of an infant
Abstract:
An 8-month-old boy was found to have a solitary hepatic mesenchymal hamartoma. Histologically, the lesion appeared as a large island of loose mesenchymal tissue with few cystic bile ducts and liver cells. Electronmicroscopy showed microvilli on the surface of tumor cells and desmosomes between the cells. Immunohistochemical studies showed that alpha-fetoprotein was localized in the proliferating liver cells and bile ductal epithelium of this neoplasm. This case is the 17th case of hepatic mesenchymal hamartoma reported in Japan.
Insights
A rare solitary hepatic mesenchymal hamartoma was identified in an 8-month-old boy. This pediatric liver tumor showed specific cellular features and alpha-fetoprotein localization.
Area of Science:
- Pediatric Pathology
- Hepatology
- Oncology
Background:
- Hepatic mesenchymal hamartoma (HMH) is a rare benign liver tumor primarily affecting infants and children.
- This report details a unique case of HMH in an 8-month-old male, contributing to the limited literature on this condition.
Observation:
- Histological examination revealed a solitary lesion characterized by loose mesenchymal tissue interspersed with cystic bile ducts and hepatocytes.
- Electron microscopy demonstrated microvilli on tumor cell surfaces and desmosomes, suggesting epithelial differentiation.
- Immunohistochemistry confirmed alpha-fetoprotein localization within the proliferating liver cells and bile ductal epithelium.
Findings:
- The case represents the 17th documented instance of hepatic mesenchymal hamartoma in Japan.
- The findings highlight the characteristic histological and ultrastructural features of HMH.
- Alpha-fetoprotein expression provides insights into the neoplastic cell origins.
Implications:
- This case expands the understanding of HMH presentation and characteristics in pediatric populations.
- The detailed pathological analysis aids in differentiating HMH from other pediatric liver tumors.
- Further research into HMH pathogenesis and molecular markers is warranted.